MedPath

Chronic Kidney Disease Japan Cohort (CKD-JAC) Study

Not Applicable
Conditions
Chronic Kidney Disease
Registration Number
JPRN-UMIN000020038
Lead Sponsor
Kyowa Hakko Kirin Co., Ltd.
Brief Summary

Refer to the article 1.Primary Endpoint:Renal event https://www.ncbi.nlm.nih.gov/pubmed/27412450 2.Primary Endpoint:CVD https://www.ncbi.nlm.nih.gov/pubmed/27884399

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
3000
Inclusion Criteria

Not provided

Exclusion Criteria

1.liver cirrhosis 2.HIV/AIDS 3.transplant recipients and patients 4.polycystic kidney disease 5.cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcomes are progression of CKD defined by reduction in eGFR, CVD events and all cause mortality
Secondary Outcome Measures
NameTimeMethod
The secondary outcomes are QOL and hospitalization.
© Copyright 2025. All Rights Reserved by MedPath